GSK Investigational Site

Avellino, Campania 83100

0 studies enrolling now · 8 studies all time

What they study most

Chronic Liver Disease, HBV, HCV, HIV Infection, Hepatitis B Virus, Hepatitis C Virus, Hepatitis C, Chronic, Human Immunodeficiency Virus, Liver Diseases, NASH - Nonalcoholic Steatohepatitis, Nausea and Vomiting, Chemotherapy-Induced, Neoplasms, Breast

Studies at this site

• Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures — Stopped early
• 24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease — Completed
• A Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting. — Completed
• LENS - Long-term Eltrombopag Observational Study — Completed
• Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment — Completed
• Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast Cancer — Completed
• Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Benefit Subjects With Hepatitis C Liver Disease — Completed
• Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Subjects With Hepatitis C Related Liver Disease — Completed